Skip to content
Article Rich – Lifestyle
Author:
Talawar Therapeutics
Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer
July 20, 2026
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
June 29, 2026